Healthcare Industry News: Positron Emission Mammography
News Release - July 19, 2007
Naviscan PET Systems Appoints Paul J. Mirabella as President and CEOSAN DIEGO, July 19 (HSMN NewsFeed) -- Naviscan PET Systems Inc., a privately held company specializing in the development of high-resolution PET scanners, announced today the appointment of Paul J. Mirabella as President, CEO and Director. He brings to the position more than 30 years of diagnostic imaging and patient care experience with GE Healthcare (GEHC).
Most recently, Mr. Mirabella was the President and CEO of Global Diagnostic Imaging at GEHC. Over his 30 years at GE, he held various leadership roles in technology, marketing and global business management in ultrasound, computed tomography (CT), magnetic resonance (MR) and sales and services.
"Throughout my career at GE, I had the pleasure of working closely with many physicians and caregivers in the field of imaging and breast cancer and it is an area that has touched my family personally," said Mr. Mirabella. "Naviscan is a great opportunity and I can think of no better reason to step out of retirement than to lead a company that has the potential to make a difference in people's lives."
Since retiring from GEHC in 2006, Mr. Mirabella has been working as a consultant and advisor for a variety of private and public companies. He is an independent director in several private companies in the healthcare industry and serves on the Research and Education Committee of the Radiological Society of North America. He is also a director in the Vince Lombardi Charitable Funds organization and an owner/director of several private companies in Wisconsin.
Mr. Mirabella holds degrees in Aerospace Engineering and Applied Mechanics from Polytechnic Institute in New York, a Masters in Mechanical Engineering from Central Florida University and is a graduate of the GE Business Management Program accredited by the University of Wisconsin-Whitewater.
About Naviscan PET Systems, Inc.
Naviscan PET Systems, founded in 1995, develops and markets compact, high-resolution PET scanners and molecular agents used for high-resolution imaging. These products are designed to help physicians and researchers diagnose and locate cancer, guide interventions, and advance new clinical therapies. The company is headquartered in San Diego, CA. For more information, please visit: http://www.naviscanpet.com
About PEM Flex(TM)
PEM Flex is the first commercially available FDA-cleared, high resolution PET scanner designed to image small body parts independently or with other imaging modalities. PEM Flex utilizes a specialized form of positron emission tomography (PET) technology called Positron Emission Mammography (PEM) which allows physicians to visualize and characterize lesions as small as 2 millimeters in size. The second generation PEM Flex Solo II is commercially available and currently used in breast centers, PET centers and hospitals across the United States.
About Sanderling Ventures
Founded in 1979, Sanderling is among the oldest investment firms dedicated to building new biomedical companies. Sanderling demonstrates that significant companies are best built in close working partnerships with entrepreneurs.
Sanderling's unique approach combines a specialized investment focus with active management and long-term commitment to ensure the highest rates-of-return for both its entrepreneurs and investors. For more information on Sanderling Ventures and its portfolios please visit http://www.sanderling.com.
Sanderling led Naviscan's Series B financing round in 2005 and participated in Series C in 2007.
Source: Naviscan PET Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.